Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis

NCT02021162 · clinicaltrials.gov ↗
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University at Buffalo

Collaborators